It's High Times for Guidelines: Cannabinoid Hyperemesis Syndrome Clinical Pathway

The pain and misery of a youngster presenting with hyperemesis can be intense – and the list of differentials overwhelming. This talk from multiple pediatric specialists presents keys to diagnosing cannabinoid hyperemesis syndrome and crucial first steps of an evaluation, including how to do a HEADSS assessment and why you need an EKG. The speakers explain which antiemetics work for CHS (and which don’t) as well as how to plan discharge to optimize outcomes for these kids. Bonuses: flowcharts for emergency and inpatient care and resources for families and providers.

Learning Objectives:

• Identify the indications, both approved and off-label, of cannabis-based antiemetics
• Examine the mechanism of action and side effects of cannabis-based antiemetics
• Review the CHS clinical pathway for ED and Inpatient
• Recognize the importance of collaboration and communication among interprofessional team members to improve outcomes and treatment efficacy for patients with cannabinoid hyperemesis syndrome (CHS)